Plain-English translation of NCT06839898 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different types of implantable lenses — the Eyecryl Phakic Toric IOL and the Visian Toric ICL — that are surgically placed in your eye to correct both nearsightedness and astigmatism at the same time. Unlike glasses or contact lenses, these clear lenses work by being implanted inside your eye while keeping your natural lens intact. The study will compare how well each treatment works and how satisfied patients are with their vision afterward.
Many people with moderate to high nearsightedness combined with astigmatism struggle to see clearly without glasses or contact lenses, and traditional surgery isn't always suitable for them. This trial exists to determine which of these two implantable lens options provides better vision improvement and outcomes for patients who need correction for both conditions.
You likely qualify if…
You likely don't qualify if…
If you qualify and are randomly assigned to one of the two treatment groups, you will undergo a surgical procedure to have one of the implantable lenses placed in your eye. Before surgery, you'll have detailed eye measurements and examinations to ensure the lens is the right fit for you. After the procedure, you'll attend multiple follow-up visits so the research team can monitor your healing, check your vision, and compare how well each lens type performs over time.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Germany
India